Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rodrigo G. Taboada"'
Tyrosine kinase inhibitors in patients with neuroendocrine neoplasms: a systematic literature review
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Several tyrosine kinase receptors inhibitors (TKIs) have demonstrated antiproliferative effects in well-differentiated neuroendocrine tumors (NETs). We aimed to summarize and appraise the current evidence of the efficacy of TKIs in patien
Externí odkaz:
https://doaj.org/article/300a9cbeb3974a56a775fbefa9029f12
Autor:
Milton J. Barros, Jonathan Strosberg, Taymeyah Al-Toubah, Victor Hugo F. de Jesus, Lais Durant, Celso A. Mello, Tiago C. Felismino, Louise De Brot, Rodrigo G. Taboada, Mauro D. Donadio, Rachel P. Riechelmann
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Nearly 30% of neuroendocrine tumors (NETs) have evidence of immunohistochemical (IHC) expression of estrogen (ER) and/or progesterone (PR) receptors. Therefore, targeting ER/PR may offer an effective NET-directed treatment to select patie
Externí odkaz:
https://doaj.org/article/56df061dcf68479e86421a29fc0f53cb
Autor:
Rachel P. Riechelmann, Rodrigo G. Taboada, Victor Hugo F. de Jesus, Michael Iglesia, Nikolaos A. Trikalinos
Publikováno v:
American Society of Clinical Oncology Educational Book.
Neuroendocrine neoplasms (NENs) comprise a beautifully complicated, exciting landscape of histologies and clinical behaviors. However, the nuanced complexity of low- and high-grade variants can easily overwhelm both patients and providers. In this ch
Autor:
Rodrigo G Taboada, Rachel P Riechelmann, Carine Mauro, Milton Barros, Richard A Hubner, Mairéad G McNamara, Angela Lamarca, Juan W Valle
Publikováno v:
The Oncologist. 27:97-103
Background Everolimus-induced pneumonitis (EiP) has been poorly studied in patients with neuroendocrine neoplasms (NEN) outside clinical trials. The aim of this study was to evaluate the incidence, risk factors, and outcomes of EiP in patients with N